Devin B. Lowe

Experimmune, Texas Tech University Health Sciences Center

Affiliated withTexas Tech University Health Sciences Center

Research Area

Immunology and Infection

Biography

Devin B. Lowe has not added Biography.
If you are Devin B. Lowe and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 3	2015

Other Publications

Article	Year
Anti-idiotype responses abrogate anti-CD4-induced tolerance to a tumor-specific antigen and promote systemic tumor immunity. Cancer immunology, immunotherapy : CII\| PubMed ID: 15156293	2004
In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization. Virology\| PubMed ID: 15661138	2005
DNA vaccines: successes and limitations in cancer and infectious disease. Journal of cellular biochemistry\| PubMed ID: 16440328	2006
Fc gamma receptors play a dominant role in protective tumor immunity against a virus-encoded tumor-specific antigen in a murine model of experimental pulmonary metastases. Journal of virology\| PubMed ID: 17108042	2007
A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17. Journal of immunological methods\| PubMed ID: 17336323	2007
Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase. Journal of virology\| PubMed ID: 19889780	2010
Role of the innate immune response and tumor immunity associated with simian virus 40 large tumor antigen. Journal of virology\| PubMed ID: 20668083	2010
Vaccines and immunotherapeutics for the treatment of malignant disease. Clinical & developmental immunology\| PubMed ID: 20936120	2010
Intratumoral IL-12 gene therapy results in the crosspriming of Tc1 cells reactive against tumor-associated stromal antigens. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 21189473	2011
CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA. Journal of virology\| PubMed ID: 21593176	2011
Chronic inflammation and immunologic-based constraints in malignant disease. Immunotherapy\| PubMed ID: 21995576	2011
Combined Tbet and IL12 gene therapy elicits and recruits superior antitumor immunity in vivo. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 22215017	2012
Vaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic mice. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 22246626	2012
Combined vaccine+axitinib therapy yields superior antitumor efficacy in a murine melanoma model. Melanoma research\| PubMed ID: 22504156	2012
The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen. Cancer immunology, immunotherapy : CII\| PubMed ID: 22926061	2013
Shock block for improved immunotherapy. Oncoimmunology\| PubMed ID: 23243617	2012
Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma. Oncoimmunology\| PubMed ID: 24734217	2014
Monitoring antigen-specific T cell responses using real-time PCR. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 25149303	2014